Literature DB >> 10564916

Prevalence of Trypanosoma cruzi and Leishmania chagasi infection and risk factors in a Colombian indigenous population.

A Corredor Arjona1, C A Alvarez Moreno, C A Agudelo, M Bueno, M C López, E Cáceres, P Reyes, S Duque Beltran, L E Güaldron, M M Santacruz.   

Abstract

This study was carried out in order to obtain base-line data concerning the epidemiology of American Visceral Leishmaniasis and Chagas' Disease in an indigenous population with whom the government is starting a dwelling improvement programme. Information was collected from 242 dwellings (1,440 people), by means of house to house interviews about socio-economic and environmental factors associated with Leishmania chagasi and Trypanosoma cruzi transmission risk. A leishmanin skin test was applied to 385 people and 454 blood samples were collected on filter paper in order to detect L. chagasi antibodies by ELISA and IFAT and T. cruzi antibodies by ELISA. T. cruzi seroprevalence was 8.7% by ELISA, L. chagasi was 4.6% and 5.1% by IFAT and ELISA, respectively. ELISA sensitivity and specificity for L. chagasi antibodies were 57% and 97.5% respectively, as compared to the IFAT. Leishmanin skin test positivity was 19%. L. chagasi infection prevalence, being defined as a positive result in the three-immunodiagnostic tests, was 17.1%. Additionally, 2.7% of the population studied was positive to both L. chagasi and T. cruzi, showing a possible cross-reaction. L. chagasi and T. cruzi seropositivity increased with age, while no association with gender was observed. Age (p<0.007), number of inhabitants (p<0. 05), floor material (p<0.03) and recognition of vector (p<0.01) were associated with T. cruzi infection, whilst age ( p<0.007) and dwelling improvement (p<0.02) were associated with L. chagasi infection. It is necessary to evaluate the long-term impact of the dwelling improvement programme on these parasitic infections in this community.

Entities:  

Mesh:

Year:  1999        PMID: 10564916     DOI: 10.1590/s0036-46651999000400005

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


  7 in total

1.  Anti-leishmania infantum IgG antibody avidity in visceral leishmaniasis.

Authors:  Monique Gomes Salles Tiburcio; Laís Anversa; Kelly Aparecida Kanunfre; Antonio Walter Ferreira; Virmondes Rodrigues Júnior; Luciana de Almeida Silva
Journal:  Clin Vaccine Immunol       Date:  2013-09-04

Review 2.  ELISA versus PCR for diagnosis of chronic Chagas disease: systematic review and meta-analysis.

Authors:  Pedro E A A Brasil; Liane De Castro; Alejandro M Hasslocher-Moreno; Luiz H C Sangenis; José U Braga
Journal:  BMC Infect Dis       Date:  2010-11-25       Impact factor: 3.090

3.  Emerging Chagas disease: trophic network and cycle of transmission of Trypanosoma cruzi from palm trees in the Amazon.

Authors:  A R Teixeira; P S Monteiro; J M Rebelo; E R Argañaraz; D Vieira; L Lauria-Pires; R Nascimento; C A Vexenat; A R Silva; S K Ault; J M Costa
Journal:  Emerg Infect Dis       Date:  2001 Jan-Feb       Impact factor: 6.883

4.  The Trypanosoma cruzi satellite DNA OligoC-TesT and Trypanosoma cruzi kinetoplast DNA OligoC-TesT for diagnosis of Chagas disease: a multi-cohort comparative evaluation study.

Authors:  Koen De Winne; Philippe Büscher; Alejandro O Luquetti; Suelene B N Tavares; Rodrigo A Oliveira; Aldo Solari; Ines Zulantay; Werner Apt; Patricio Diosque; Mercedes Monje Rumi; Nuria Gironès; Manuel Fresno; Rogelio Lopez-Velez; José A Perez-Molina; Begoña Monge-Maillo; Lineth Garcia; Stijn Deborggraeve
Journal:  PLoS Negl Trop Dis       Date:  2014-01-02

5.  Integrating evidence, models and maps to enhance Chagas disease vector surveillance.

Authors:  Alexander Gutfraind; Jennifer K Peterson; Erica Billig Rose; Claudia Arevalo-Nieto; Justin Sheen; Gian Franco Condori-Luna; Narender Tankasala; Ricardo Castillo-Neyra; Carlos Condori-Pino; Priyanka Anand; Cesar Naquira-Velarde; Michael Z Levy
Journal:  PLoS Negl Trop Dis       Date:  2018-11-29

Review 6.  Identification of asymptomatic Leishmania infections: a scoping review.

Authors:  Ana Victoria Ibarra-Meneses; Audrey Corbeil; Victoria Wagner; Chukwuemeka Onwuchekwa; Christopher Fernandez-Prada
Journal:  Parasit Vectors       Date:  2022-01-05       Impact factor: 3.876

Review 7.  Factors associated with visceral leishmaniasis in the americas: a systematic review and meta-analysis.

Authors:  Vinícius Silva Belo; Guilherme Loureiro Werneck; David Soeiro Barbosa; Taynãna César Simões; Bruno Warlley Leandro Nascimento; Eduardo Sérgio da Silva; Claudio José Struchiner
Journal:  PLoS Negl Trop Dis       Date:  2013-04-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.